The cellular pathways that control the sneeze reflex go far beyond the sinuses and until recently have been poorly understood. A recent mouse model study published in Cell has identified […]

The cellular pathways that control the sneeze reflex go far beyond the sinuses and until recently have been poorly understood. A recent mouse model study published in Cell has identified […]
Olfactory dysfunction (OD) has long been considered a symptom of COVID-19, but its use in COVID-19 testing can be questionable, as subjective olfactory tests can significantly underreport OD. A new […]
The retronasal olfactory test, a psychophysical odor test performed using an orally presented stimulus, can be used to differentiate normosmic and hyposmic cases.
Study participants with sinonasal inflammation show decreased brain connectivity within a major functional hub with a central role in modulation cognition.
The anterior table defect poses a reconstructive challenge, and very few publications have described reconstructive options.
Existing evidence suggests that olfactory training is a low-risk intervention that provides clinically relevant and sustained benefit in some PISL patients.
Evidence indicates that the prevalence of olfactory dysfunction in COVID-19 patients is 48.85%.
A look at the characteristics associated with avoidance of daily activities in patients with chronic rhinosinusitis.
Otolaryngology experts examined important clinical questions in five areas—from antivirals for newborn hearing to tonsillar cancer—during the Triological Society’s “Best Practices” session.
New but limited data have emerged suggesting that oral steroids with olfactory training may be a safe and effective treatment for loss of smell due to COVID-19.